A recent breakthrough in the treatment of cancer in Russia is the creation of an individualised mRNA-based cancer vaccine, called Enteromix, which has demonstrated excellent safety and 100 per cent efficacy in early clinical trials. This is a new therapy that can transform the way cancer is treated in the world, giving patients a more safer and effective alternative to the conventional therapy such as chemotherapy and radiation.

What Is Enteromix?

Enteromix is a new type of cancer vaccine developed by mRNA technology (the same highly developed technology of the COVID-19 vaccines). Enteromix does not involve any harsh, nonspecific methods used in conventional cancer treatments, but rather trains the immune system of the patient to recognise and eliminate the cancer cells specifically, which minimises tumour size and slows the progression of cancer with minimal side effects.

The vaccine is personalized to each patient and it is designed according to the RNA tumour profile of the patient. This immunotherapy is highly targeted and immunotherapy against cancer associated with viruses and independent of viruses since it is precise to each person and very effective against both virus-related and non-virus-related cancer. 

Recent Clinical Trial Results

The trials were organised by the Federal Medical and Biological Agency (FMBA) of Russia and by the National Medical Research Radiological Centre and were originally targeted at patients with colorectal cancer, which is the second largest cause of cancer mortality in the world. The experiments were done on 48 volunteers and demonstrated reduction of tumours by 60-100 percent and increased survival rates dramatically. No major adverse effects of the use of the vaccine were observed and it was reported to be safe even when used repeatedly.

In 2025, the FMBA of Russia confirmed at the Eastern Economic Forum that it is awaiting regulatory approval, and would begin clinical use starting in September-October 2025. Studies are also in progress to design vaccine variants against other aggressive cancers such as glioblastoma (brain cancer) and melanoma (skin cancer). 

How Does the Vaccine Work?

Enteromix is based on the three-step process that is driven by the high-tech AI and molecular biology:

  • Genetic Profiling: With the help of AI algorithms, researchers determine the tumour genetics of a patient and generate a personal mRNA blueprint. 
  • mRNA Synthesis:The vaccine molecules are produced to encode particular cancer-related peptides that activate the immune system to attack the cancer. 
  • Immune Activation: The vaccine, once introduced, educates the immune system to kill not just the tumours but metastatic tumour cells too.  

International and Future Outlook 

Provided that these findings are supported by large-scale trials in the future, Enteromix would transform the treatment of cancer on a global level, moving away to personalised immunotherapy instead of generalised chemotherapy. The success of the vaccine may particularly impact highly-cancer-burdened countries, such as India, where access to advanced treatment is still restricted.

Scientists in the globe are observing keenly, with optimism that the Enteromix would open the door to other mRNA-based cancer vaccines, which would increase alternatives against fatal cancers with dismal prognoses.

The Enteromix cancer vaccine by Russia is leading the future of medical innovation and is a combination of groundbreaking technology, artificial intelligence, and personalized medicine that provides hope in the fight against cancer. Having regulatory approval soon, this vaccine will transform the lives of millions of people as it will introduce a safer and more effective means of fighting one of the toughest diseases humans have ever faced.

In a path-breaking effort, GSVM Medical College in Kanpur is planning to make its patient care more efficient through new technology. The college will deploy AI-supported smart mattresses for serious patients. These smart mattresses will immediately notify doctors and nurses through an alarm the moment a patient's condition worsens, allowing instant medical attention and possibly saving lives. Importantly, the college provides treatment to patients from Kanpur and about 18 surrounding districts, helping thousands.

Code Blue Out: Alerts Now Directly to Staff

Doctors and nurses previously used the code phrase 'Code Blue' when a patient's condition rapidly fell apart. Smart mattresses now send an alarm and red alert directly to the doctor's and nurse's phone, tablet, or computer the instant a patient's condition worsens.

For example, if a patient's heart rate suddenly reaches 150, a beeping alarm comes on the screen, allowing the doctor to act in time.

Smart Mattresses To Be Installed In Batches Of 10

Dr. Sanjay Kala, principal of GSVM Medical College, stated that the installation of 10 smart mattresses, each worth about Rs 5 lakh, is under progress. The equipment will be purchased from the CSR fund. 10 mattresses will be initially deployed, and the number may be increased subsequently. GSVM would thus become the first government medical college in the state to employ this sophisticated technology.

Round-The-Clock Monitoring For Critical Patients

Dr. Kala told us that patients with serious diseases tend to have gradual internal deterioration, meaning they need constant 24-hour care. Earlier, the physicians and nurses used coordination without machinery, but with the intelligent mattresses, it will be easier to monitor and help in quicker treatment and possibly lowering mortality rates.

District Patients To Benefit Nearby

GSVM Medical College, which is the Bundelkhand region's largest medical school and 18 surrounding districts, has thousands of patients visited by it every day. With the addition of smart mattresses, patients now have the benefit of up-to-date care, further giving doctors the power to save lives.

A new AI-powered stethoscope developed in the UK is making headlines for its ability to detect heart failure, atrial fibrillation, and heart valve disease in just 15 seconds, a feat that could transform early diagnosis and treatment of serious heart conditions.

What Is the Working Principle of an AI Stethoscope?

The device relies on highly sophisticated artificial intelligence to detect subtle changes to heartbeat and blood flow which cannot be detected by human ears. Meanwhile, it captures a rapid ECG to monitor the electrical activity of the heart. This data is uploaded to the cloud, where specialized algorithms, which are trained using the data of thousands of patients, can rapidly process the findings and return them to the doctor via his smartphone.

Findings of Real-Life Trials.

In a major study involving over 200 GP clinics and more than 1.5 million patients, those checked with this AI stethoscope were nearly twice as likely to be diagnosed with heart failure, more than three times as likely to have atrial fibrillation detected, and almost twice as likely to have heart valve disease identified, compared to those diagnosed by standard methods. This rapid diagnosis ensures patients receive appropriate treatment as early as possible, potentially life-saving.

Impact and Challenges

According to doctors and experts, this device can be referred to as a game-changer because most instances of heart failure are normally detected only when patients are in a critical state and unable to reach the hospital. Early diagnosis could drastically reduce emergency cases, improve outcomes, and simplify the process for busy clinics, especially in places with limited resources. But experiments indicated that approximately 70% of the clinics that got the device failed to use it after a year, largely due to the fact that the technology must be more imbued in the day to day life of its users.

Healthcare Advancement via AI Technologies

The stethoscope with AI will be a significant advancement in the way physicians and other healthcare professionals can identify heart issues early, particularly in large clinics and underserved communities. By quickly analysing heart sounds and ECG patterns using advanced algorithms, this technology enables primary care providers in India to diagnose heart failure, atrial fibrillation, and heart valve diseases in seconds, making it possible to start life-saving treatment much sooner. The availability of these tools to provide rapid and accurate diagnosis of cardiologists with only 4,000 serving more than 1.3 billion people, particularly in rural areas, bridges a very important gap of these frontline personnel screening patients who present with symptoms of breathlessness or fatigue and immediately referring them to specialists for further treatment.

AI Stethoscope in India 

When introduced in India, AI stethoscopes would transform diagnostic care in cities and remote areas alike by letting it be conducted by highly-trained specialists less frequently and allowing it to be conducted with data consistency and precision. Not only does it translate to a reduction in preventable complications and hospital emergencies, but it also assists in bringing affordable, scalable technology to the masses. The devices already developed and implemented in medical facilities in Karnataka and Maharashtra (India) like AiSteth showed more than 93% accuracy, and have already screened thousands of patients, demonstrating their potential . 

The Future of Cardiac Care

As the world moves ahead with AI advances, companies like Eko Health (a US-based country) are creating AI stethoscope-like healthcare tools by combining classic medical tools with smart computing power, which will lead the evolution of healthcare across the globe. Researchers, as of now, are planning to roll out these AI-powered stethoscopes to more clinics across Wales, London, and Sussex, hoping for widespread use and better heart health for people everywhere in the country.  

The innovation combines the simplicity of technology with the power of artificial intelligence, merging the simplest tools that can be found in any clinic and integrating them with cloud data analysis making it applicable in the daily environment of healthcare. The success of this AI stethoscope shows the role of innovation in the healthcare sector and the ability of even the most basic gadgets to be enhanced to save lives with smarter solutions.

The Central Board of Secondary Education (CBSE) and All India Institute of Medical Sciences (AIIMS) Delhi have introduced a five-day offline training programme under the Project MATE (Mind Activation Through Education). The training programme, which starts today, on August 26 at the AIIMS Delhi and will continue until August 30.

As per CBSE, Project MATE has been conceptualized by AIIMS Delhi as an adolescent well-being programme intended to improve resilience, develop coping skills, and reinforce peer connection via the "MATE-5" framework. 

The program first engages around 50 counselors and well-being teachers of CBSE-affiliated institutions of the Delhi-NCR area.

The five-day training is being conducted by professionals from the fields of psychiatry, psychology, and communication. Sessions include a range of topics from the biopsychosocial model of health, nutrition, family and social roles, anxiety coping, counseling styles, and electronic well-being. The trainees will also be trained in parental sensitisation, impact assessment tools, and creating peer support structures.

In the first session, both CBSE officials and AIIMS officials stressed the importance of incorporating education and health for student welfare. As per an official report, the programme aims to provide school counselors with structured frameworks to tackle problems like stress, loneliness, and emotional alienation among students.

This partnership will enable CBSE and AIIMS to equip school counselors with evidence-based tools that enhance emotional resilience, conflict resolution, and social connectedness among students.

CBSE stated that the results of this pilot training would be followed up regularly and, depending on the outcome, the programme could then be scaled up for national implementation. The officials said that the initiative will deepen the school counseling ecosystem, advance early interventions in adolescents' mental health, and standardize mental health as integral to overall well-being.

The Enforcement Directorate has busted a gigantic scam for MBBS admissions in which bogus documents were employed to gain admission in medical colleges under the Non-Resident Indian (NRI) quota.

 

The investigation, with help from the Ministry of External Affairs and Indian missions, discovered that private medical colleges provided around 18,000 seats in the MBBS course to candidates who utilized bogus documents, as per an NDTV report. 

 

The enforcement body discovered in the investigation that the colleges remitted fees to the agents for creating bogus documents, such as embassy documents and bogus family trees.

 

In most instances, the agents and the medical colleges utilized a single set of documents for multiple candidates.

 

The racket also included some real NRI students whose names were used by the agents after offering them money.

 

The ED raided such colleges and seized a number of fake NRI certificates and notary officer stamps employed in the US.

 

According to the norms, the admission fees for the NRI quota have to be remitted by an NRI relative. But ED discovered during its investigation that the fees in the majority of cases were not remitted by the NRI relatives.

 

The ED last month stated that the governments in West Bengal and Odisha failed to act against the admission of ineligible students in some private medical colleges under the NRI quota even after the MEA furnished "categorical" details of "forgery".

 

It had confiscated "incriminating" material in this case during raids in the past, it further added.

 

The ED informed that a fixed deposit of Rs 6.42 crore of a West Bengal-based private college was provisionally attached. Previously, the enforcement agency attached assets of some colleges and individuals concerned in these suspected irregularities worth Rs 12.33 crore.

 

"Though there is categorical information of forgery in instances of some NRI sponsors furnished by the Ministry of External Affairs, no action has been taken by concerned state governments," the investigation agency said.

Nita Ambani, Founder and chairperson of Reliance announced a massive healthcare project of a 2000-bed medical city in Mumbai, Maharashtra. In the 48th Annual General Meeting on August 29, of Reliance Industries, she emphasised this ambitious new healthcare initiative which will revolutionize medical care in India. This facility will not only  be a new hospital but a center of medical innovation managed by artificial intelligence-based diagnostics, advanced technology, and state-of-the-art medical services. 

 

48th AGM Announcement 

Nita Ambani stated at the AGM, “We hope our country will be proud of it, and the world will look up to it.” This facility is aiming to align with India's growing push towards integrating AI and precision medicine in healthcare delivery, which shall further enhance the quality and accessibility for all sections of the society. She also described the medical city as “India’s new beacon of healthcare innovation,” emphasizing that it will merge “AI-powered diagnostics, cutting-edge medical technology, and some of the finest doctors from India and the world” to elevate standards of care. 

 

She expressed the Foundation’s promise of holistic and compassionate care by opening “Jeevan,” a new wing focused on chemotherapy and immunotherapy, with a particular focus on pediatric cancer. “This wing will be designed to heal our little ones with world-class care and a mother’s warmth,” she said, highlighting their focus on vulnerable groups. 

 

This massive medical city will represent Reliance Foundation’s longstanding philosophy of “Respect for Life,” building on the decade-long legacy of the Sir HN Reliance Foundation Hospital which has treated over 3.3 million patients and is ranked among India’s top multi-specialty hospitals. 

 

What Will the Medical City Have? 

Beyond patient care, the Reliance medical city will house a transformative medical college aimed at nurturing future generations of doctors to serve India and the global community. This two-purpose emphasis on state-of-the-art care and education highlights a mission of democratizing the treatment of the best healthcare and thus making healthcare affordable and available to all socio-economic groups.

 

The integration of AI in diagnostics and treatment pathways marks a significant leap forward for Indian healthcare infrastructure. AI-powered tools will enhance early detection, precision treatment, and streamline workflow, enabling doctors to deliver personalized medicine efficiently. Emphasis on technology and low-cost care also tackles the two issues facing India in healthcare quality and accessibility, which is expected to become a $372 billion industry by 2027. 

 

Health Mission Of India

Reliance Foundation’s medical city aligns with India’s national health mission to expand healthcare infrastructure and promote innovation in medicine. It also resonates with global trends, as healthcare systems worldwide increasingly leverage AI and digital technologies to improve outcomes and reduce costs.

 

In short, the project represents a new dawn in cooperative healthcare and health education in India, a combination of innovation, empathy, and accessibility. As Reliance Foundation steps forward with this visionary initiative, it sets a benchmark for philanthropic investment in healthcare, inspiring others to envision a future where high-quality medical care is within everyone’s reach. 

 

 



In a noteworthy policy decision meant to aid healthcare trainees, the Delhi government on Tuesday cleared a huge hike in the nursing interns' monthly stipend. The new stipend will be ₹13,150, from the previous ₹500.

 

Chief Minister Rekha Gupta announced the revision after a Cabinet meeting, terming the modification as "long overdue" and a step toward acknowledging the key role played by nursing interns in the city's healthcare system.

 

The raised stipend will be introduced with immediate effect and will accrue to all deserving nursing interns who are in training now," Gupta stated. "Not only does this bring down the financial burden on students but also brings Delhi up to mark with the central government's standards for healthcare stipends. 

 

The move is likely to help hundreds of interns working in government hospitals and nursing schools in the capital. The earlier stipend had not seen a hike for years, and criticism from health workers and student groups was widespread.

 

The hike matches Delhi with other states that have already adjusted their assistance for trainee doctors in the wake of the COVID-19 pandemic, when nursing staff filled frontline positions.

 

During the same Cabinet meeting, the government also approved the launch of Delhi Mitra App, which is a public grievance redressal system to facilitate citizen complaints across departments. The app is meant to create a single digital interface for processing problems related to civic services, infrastructure, and governance.

 

The two announcements are indicative of the government's increased emphasis on public welfare and e-governance and responding to longstanding requests in the healthcare education sector.

More Articles ...